1.
Sustained delivery and expression of DNA encapsulated in polymeric nanoparticles
by H Cohen
Gene Therapy, 2000, Vol.7(22), p.1896

2.
An immobilized nanoparticle-based platform for efficient gene knockdown of targeted cells in the circulation.(ORIGINAL ARTICLE)(Report)
by Huang, Z.
Gene Therapy, Oct, 2009, Vol.16(10), p.1271(12)

3.
Genospheres: self-assembling nucleic acid-lipid nanoparticles suitable for targeted gene delivery
by Hayes, M
Gene Therapy, Apr 2006, pp.646-51

4.
Cytosolic delivery of antisense oligonucleotides by listeriolysin O-containing liposomes
by Mathew, E
Gene Therapy, Jul 1, 2003, pp.1105-15

5.

6.
Transfer of bcl-xs plasmid is effective in preventing and inhibiting rat hepatocellular carcinoma induced by N-nitrosomorpholine
by Baba, M
Gene Therapy, Aug 2001, pp.1149-56

7.
Characterisation of LMD virus-like nanoparticles self-assembled from cationic liposomes, adenovirus core peptide [mu] (mu) and plasmid DNA
by Tagawa, T
Gene Therapy, May 2002, pp.564-76

8.
A novel N-acyl phosphatidylethanolamine-containing delivery vehicle for spermine-condensed plasmid DNA
by Shangguan, T
Gene therapy, May 2000, Vol.7(9), pp.769-83

9.
A combinatorial approach for targeted delivery using small molecules and reversible masking to bypass nonspecific uptake in vivo
by Shi, Q
Gene Therapy, Sep 2010, pp.1085-97

10.
Biology and application of alphaviruses in gene therapy
by Lundstrom, K
Gene Therapy, Oct 2005, pp.S92-7

11.
Efficient delivery of liposome-mediated MGMT-siRNA reinforces the cytotoxity of temozolomide in GBM-initiating cells
by Kato, T
Gene Therapy, Nov 2010, pp.1363-71

12.
Gene therapy progress and prospects: non-viral gene therapy by systemic delivery
by S-D, Li
Gene Therapy, Sep 2006, pp.1313-9

13.
Pre-clinical evaluation of liposomal gene transfer to improve dermal and epidermal regeneration
by Branski, L
Gene Therapy, Jun 2010, pp.770-8

14.
Electroporation-mediated transfer of plasmids to the lung results in reduced TLR9 signaling and inflammation
by Zhou, R
Gene Therapy, May 2007, Vol.14(9), pp.775-80

15.
Development of a novel systemic gene delivery system for cancer therapy with a tumor-specific cleavable PEG-lipid
by Hatakeyama, H
Gene Therapy, Jan 2007, pp.68-77

16.
Stabilized plasmid-lipid particles for systemic gene therapy
by Tam, P
Gene Therapy, Nov 2000, pp.1867-74

17.
STAT-1 decoy oligonucleotide improves microcirculation and reduces acute rejection in allogeneic rat small bowel transplants
by Stojanovic, T
Gene Therapy, Jun 2007, pp.883-90

18.
Gene therapy in wound healing: present status and future directions
by Branski, L
Gene Therapy, Jan 2007, pp.1-10

19.
Intracellular trafficking of nonviral vectors
by Medina-Kauwe, L
Gene Therapy, Dec 2005, pp.1734-1751

20.
Activation of TLR9 by incorporated pDNA within PEG-coated lipoplex enhances anti-PEG IgM production
by Hashimoto, Y
Gene Therapy, Jun 2014, pp.593-8
